Neuropeptide Y receptor Y5: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
m (Bot: HTTP→HTTPS) |
||
Line 1: | Line 1: | ||
< | {{Infobox_gene}} | ||
{{ | '''Neuropeptide Y receptor type 5''' is a [[protein]] that in humans is encoded by the ''NPY5R'' [[gene]].<ref name="pmid8700207">{{cite journal | vauthors = Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL | title = A receptor subtype involved in neuropeptide-Y-induced food intake | journal = Nature | volume = 382 | issue = 6587 | pages = 168–71 | date = Jul 1996 | pmid = 8700207 | pmc = | doi = 10.1038/382168a0 }}</ref><ref name="pmid9417917">{{cite journal | vauthors = Lutz CM, Richards JE, Scott KL, Sinha S, Yang-Feng TL, Frankel WN, Thompson DA | title = Neuropeptide Y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide Y and peptide YY | journal = Genomics | volume = 46 | issue = 2 | pages = 287–90 | date = Dec 1997 | pmid = 9417917 | pmc = | doi = 10.1006/geno.1997.5024 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: NPY5R neuropeptide Y receptor Y5| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4889| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
}} | |||
== Selective ligands == | |||
< | === Agonists === | ||
* [[Neuropeptide Y]] (endogenous agonist, non subtype selective) | |||
* BWX-46 (selective NPY<sub>5</sub> agonist, CAS# 172997-92-1) | |||
* [[Peptide YY]] | |||
==See also== | === Antagonists === | ||
* CGP-71683 (CAS# 192322-50-2) | |||
* FMS-586<ref name="pmid16436501">{{cite journal | vauthors = Kakui N, Tanaka J, Tabata Y, Asai K, Masuda N, Miyara T, Nakatani Y, Ohsawa F, Nishikawa N, Sugai M, Suzuki M, Aoki K, Kitaguchi H | title = Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 317 | issue = 2 | pages = 562–70 | date = May 2006 | pmid = 16436501 | doi = 10.1124/jpet.105.099705 }}</ref> | |||
* L-152,804 (CAS# 6508-43-6) | |||
* [[Lu AA-33810]]<ref name="pmid19098165">{{cite journal | vauthors = Walker MW, Wolinsky TD, Jubian V, Chandrasena G, Zhong H, Huang X, Miller S, Hegde LG, Marsteller DA, Marzabadi MR, Papp M, Overstreet DH, Gerald CP, Craig DA | title = <nowiki>The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity</nowiki> | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 328 | issue = 3 | pages = 900–11 | date = Mar 2009 | pmid = 19098165 | doi = 10.1124/jpet.108.144634 }}</ref> | |||
* MK-0557<ref name="pmid17979781">{{cite journal | vauthors = MacNeil DJ | title = NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs | journal = Current Topics in Medicinal Chemistry | volume = 7 | issue = 17 | pages = 1721–33 | year = 2007 | pmid = 17979781 | doi = 10.2174/156802607782341028 | url = http://www.bentham-direct.org/pages/content.php?CTMC/2007/00000007/00000017/0009R.SGM }}</ref> | |||
* NTNCB (CAS# 486453-65-0)<ref name="pmid12067557">{{cite journal | vauthors = Islam I, Dhanoa D, Finn J, Du P, Walker MW, Salon JA, Zhang J, Gluchowski C | title = Discovery of potent and selective small molecule NPY Y5 receptor antagonists | journal = Bioorganic & Medicinal Chemistry Letters | volume = 12 | issue = 13 | pages = 1767–9 | date = Jul 2002 | pmid = 12067557 | doi = 10.1016/S0960-894X(02)00287-1 | url = http://linkinghub.elsevier.com/retrieve/pii/S0960894X02002871 }}</ref> | |||
* [[Velneperit]] (S-2367) | |||
== See also == | |||
* [[Neuropeptide Y receptor]] | * [[Neuropeptide Y receptor]] | ||
{{clear}} | |||
==References== | == References == | ||
{{ | {{Reflist|33em}} | ||
==Further reading== | == Further reading == | ||
{{refbegin | | {{refbegin|33em}} | ||
* {{cite journal | vauthors = Parker E, Van Heek M, Stamford A | title = Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status | journal = European Journal of Pharmacology | volume = 440 | issue = 2-3 | pages = 173–87 | date = Apr 2002 | pmid = 12007534 | doi = 10.1016/S0014-2999(02)01427-9 }} | |||
* {{cite journal | vauthors = Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML | title = Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior | journal = The Journal of Biological Chemistry | volume = 271 | issue = 42 | pages = 26315–9 | date = Oct 1996 | pmid = 8824284 | doi = 10.1074/jbc.271.42.26315 }} | |||
*{{cite journal | * {{cite journal | vauthors = Herzog H, Darby K, Ball H, Hort Y, Beck-Sickinger A, Shine J | title = Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation | journal = Genomics | volume = 41 | issue = 3 | pages = 315–9 | date = May 1997 | pmid = 9169127 | doi = 10.1006/geno.1997.4684 }} | ||
* {{cite journal | vauthors = Nichol KA, Morey A, Couzens MH, Shine J, Herzog H, Cunningham AM | title = Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control | journal = The Journal of Neuroscience | volume = 19 | issue = 23 | pages = 10295–304 | date = Dec 1999 | pmid = 10575027 | doi = }} | |||
*{{cite journal | * {{cite journal | vauthors = Rodriguez M, Audinot V, Dromaint S, Macia C, Lamamy V, Beauverger P, Rique H, Imbert J, Nicolas JP, Boutin JA, Galizzi JP | title = Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform | journal = The Biochemical Journal | volume = 369 | issue = Pt 3 | pages = 667–73 | date = Feb 2003 | pmid = 12398768 | pmc = 1223119 | doi = 10.1042/BJ20020739 }} | ||
*{{cite journal | * {{cite journal | vauthors = Berglund MM, Schober DA, Statnick MA, McDonald PH, Gehlert DR | title = The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 306 | issue = 1 | pages = 147–56 | date = Jul 2003 | pmid = 12665544 | doi = 10.1124/jpet.103.051227 }} | ||
*{{cite journal | * {{cite journal | vauthors = Beauverger P, Rodriguez M, Nicolas JP, Audinot V, Lamamy V, Dromaint S, Nagel N, Macia C, Léopold O, Galizzi JP, Caignard DH, Aldana I, Monge A, Chomarat P, Boutin JA | title = Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay | journal = Cellular Signalling | volume = 17 | issue = 4 | pages = 489–96 | date = Apr 2005 | pmid = 15601626 | doi = 10.1016/j.cellsig.2004.09.006 }} | ||
* {{cite journal | vauthors = Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z | title = Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors | journal = FASEB Journal | volume = 20 | issue = 11 | pages = 1924–6 | date = Sep 2006 | pmid = 16891622 | doi = 10.1096/fj.05-4770fje }} | |||
*{{cite journal | * {{cite journal | vauthors = Coletta DK, Schneider J, Stern MP, Blangero J, DeFronzo RA, Duggirala R, Jenkinson CP | title = Association of neuropeptide Y receptor Y5 polymorphisms with dyslipidemia in Mexican Americans | journal = Obesity | volume = 15 | issue = 4 | pages = 809–15 | date = Apr 2007 | pmid = 17426313 | doi = 10.1038/oby.2007.610 }} | ||
*{{cite journal | |||
*{{cite journal | |||
*{{cite journal | |||
*{{cite journal | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | == External links == | ||
{{G protein-coupled receptors}} | * {{cite web | url = http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2372 | title = Neuropeptide Y Receptors: Y<sub>5</sub> | accessdate = | authorlink = | date = | format = | work = IUPHAR Database of Receptors and Ion Channels | publisher = International Union of Basic and Clinical Pharmacology | pages = | archiveurl = | archivedate = | quote = }} | ||
{{G protein-coupled receptors|g1}} | |||
{{Neuropeptidergics}} | |||
[[Category:G protein coupled receptors]] | [[Category:G protein coupled receptors]] | ||
{{ | |||
{{transmembranereceptor-stub}} |
Revision as of 15:53, 6 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Neuropeptide Y receptor type 5 is a protein that in humans is encoded by the NPY5R gene.[1][2][3]
Selective ligands
Agonists
- Neuropeptide Y (endogenous agonist, non subtype selective)
- BWX-46 (selective NPY5 agonist, CAS# 172997-92-1)
- Peptide YY
Antagonists
- CGP-71683 (CAS# 192322-50-2)
- FMS-586[4]
- L-152,804 (CAS# 6508-43-6)
- Lu AA-33810[5]
- MK-0557[6]
- NTNCB (CAS# 486453-65-0)[7]
- Velneperit (S-2367)
See also
References
- ↑ Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL (Jul 1996). "A receptor subtype involved in neuropeptide-Y-induced food intake". Nature. 382 (6587): 168–71. doi:10.1038/382168a0. PMID 8700207.
- ↑ Lutz CM, Richards JE, Scott KL, Sinha S, Yang-Feng TL, Frankel WN, Thompson DA (Dec 1997). "Neuropeptide Y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide Y and peptide YY". Genomics. 46 (2): 287–90. doi:10.1006/geno.1997.5024. PMID 9417917.
- ↑ "Entrez Gene: NPY5R neuropeptide Y receptor Y5".
- ↑ Kakui N, Tanaka J, Tabata Y, Asai K, Masuda N, Miyara T, Nakatani Y, Ohsawa F, Nishikawa N, Sugai M, Suzuki M, Aoki K, Kitaguchi H (May 2006). "Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor". The Journal of Pharmacology and Experimental Therapeutics. 317 (2): 562–70. doi:10.1124/jpet.105.099705. PMID 16436501.
- ↑ Walker MW, Wolinsky TD, Jubian V, Chandrasena G, Zhong H, Huang X, Miller S, Hegde LG, Marsteller DA, Marzabadi MR, Papp M, Overstreet DH, Gerald CP, Craig DA (Mar 2009). "The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity". The Journal of Pharmacology and Experimental Therapeutics. 328 (3): 900–11. doi:10.1124/jpet.108.144634. PMID 19098165.
- ↑ MacNeil DJ (2007). "NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs". Current Topics in Medicinal Chemistry. 7 (17): 1721–33. doi:10.2174/156802607782341028. PMID 17979781.
- ↑ Islam I, Dhanoa D, Finn J, Du P, Walker MW, Salon JA, Zhang J, Gluchowski C (Jul 2002). "Discovery of potent and selective small molecule NPY Y5 receptor antagonists". Bioorganic & Medicinal Chemistry Letters. 12 (13): 1767–9. doi:10.1016/S0960-894X(02)00287-1. PMID 12067557.
Further reading
- Parker E, Van Heek M, Stamford A (Apr 2002). "Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status". European Journal of Pharmacology. 440 (2–3): 173–87. doi:10.1016/S0014-2999(02)01427-9. PMID 12007534.
- Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML (Oct 1996). "Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior". The Journal of Biological Chemistry. 271 (42): 26315–9. doi:10.1074/jbc.271.42.26315. PMID 8824284.
- Herzog H, Darby K, Ball H, Hort Y, Beck-Sickinger A, Shine J (May 1997). "Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation". Genomics. 41 (3): 315–9. doi:10.1006/geno.1997.4684. PMID 9169127.
- Nichol KA, Morey A, Couzens MH, Shine J, Herzog H, Cunningham AM (Dec 1999). "Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control". The Journal of Neuroscience. 19 (23): 10295–304. PMID 10575027.
- Rodriguez M, Audinot V, Dromaint S, Macia C, Lamamy V, Beauverger P, Rique H, Imbert J, Nicolas JP, Boutin JA, Galizzi JP (Feb 2003). "Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform". The Biochemical Journal. 369 (Pt 3): 667–73. doi:10.1042/BJ20020739. PMC 1223119. PMID 12398768.
- Berglund MM, Schober DA, Statnick MA, McDonald PH, Gehlert DR (Jul 2003). "The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction". The Journal of Pharmacology and Experimental Therapeutics. 306 (1): 147–56. doi:10.1124/jpet.103.051227. PMID 12665544.
- Beauverger P, Rodriguez M, Nicolas JP, Audinot V, Lamamy V, Dromaint S, Nagel N, Macia C, Léopold O, Galizzi JP, Caignard DH, Aldana I, Monge A, Chomarat P, Boutin JA (Apr 2005). "Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay". Cellular Signalling. 17 (4): 489–96. doi:10.1016/j.cellsig.2004.09.006. PMID 15601626.
- Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z (Sep 2006). "Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors". FASEB Journal. 20 (11): 1924–6. doi:10.1096/fj.05-4770fje. PMID 16891622.
- Coletta DK, Schneider J, Stern MP, Blangero J, DeFronzo RA, Duggirala R, Jenkinson CP (Apr 2007). "Association of neuropeptide Y receptor Y5 polymorphisms with dyslipidemia in Mexican Americans". Obesity. 15 (4): 809–15. doi:10.1038/oby.2007.610. PMID 17426313.
External links
- "Neuropeptide Y Receptors: Y5". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it. |